In short: An LDL cholesterol of 3.6 mmol/L (about 140 mg/dL) is above every target in the European ESC/EAS guideline (2019, updated 2025) – including the target for people at low cardiovascular risk (below 3.0 mmol/L). Whether it needs treatment depends on your overall risk: for healthy people without other risk factors, lifestyle measures usually come first, whereas after a heart attack the value is clearly too high.
LDL cholesterol is often called “bad” cholesterol because it can build up in artery walls and promote atherosclerosis. There is therefore no single “normal value” for everyone: the higher the risk of heart attack and stroke, the lower LDL should be.
Targets by risk (ESC/EAS)
| Cardiovascular risk | LDL target (mmol/L) | LDL target (mg/dL) | Is 3.6 mmol/L on target? |
|---|---|---|---|
| Low | below 3.0 | below 116 | no, slightly above |
| Moderate | below 2.6 | below 100 | no |
| High | below 1.8 and at least a 50% reduction | below 70 | no, well above |
| Very high (e.g. after a heart attack or stroke) | below 1.4 and at least a 50% reduction | below 55 | no, well above |
Your risk category is determined by a doctor – based on age, sex, blood pressure, smoking, diabetes, kidney function and known vascular disease, among other factors. For people without known cardiovascular disease, the guideline uses the SCORE2 (under 70) and SCORE2-OP (70 and over) risk charts. An LDL of 4.9 mmol/L (190 mg/dL) or more counts as high risk on its own and may point to an inherited lipid disorder. Laboratories sometimes give their own reference ranges; what matters for treatment is the assessment of overall risk.
What affects the value?
- Genes: inheritance strongly influences LDL. Familial hypercholesterolaemia often causes very high levels from a young age.
- Diet: a lot of saturated fat (fatty meat, processed meat, butter, cream) and trans fats raises LDL.
- Body weight and activity: excess weight and lack of exercise have an unfavourable effect.
- Other conditions and medicines: for example an underactive thyroid, kidney disease or certain medicines.
- Life stage: in women, LDL often rises after the menopause.
What you can do
- Have your overall risk assessed: ask for your blood pressure, blood sugar and cardiovascular risk to be checked – only then is it clear how important lowering LDL is.
- Change your diet: replace saturated fats with unsaturated ones (vegetable oils, nuts, fish), eat more vegetables, pulses and wholegrains and plenty of fibre.
- Be active regularly and aim for a healthy body weight.
- Do not smoke: smoking raises vascular risk regardless of cholesterol.
- Measure Lp(a) once: the guideline recommends measuring lipoprotein(a) at least once in a lifetime; a level above 50 mg/dL (about 105 nmol/L) counts as an additional risk factor.
- Medicines such as statins may be appropriate if your overall risk requires it. Decide on starting and choosing them together with your doctor.
Frequently asked questions
Is an LDL of 140 mg/dL dangerous?
A single value says little about immediate danger. Over time, an LDL of 3.6 mmol/L (140 mg/dL) increases the risk of plaque in the arteries, especially with other risk factors. How important lowering it is only becomes clear from your overall risk.
Do I need statins with an LDL of 3.6 mmol/L?
Not necessarily. At low risk, lifestyle measures are usually recommended first. At high or very high risk, for example after a heart attack, the guideline generally recommends lowering LDL with medication.
How quickly can diet lower LDL?
A change in diet can lower LDL within a few weeks. How much varies between people and also depends on genes. A repeat test after a few weeks to months shows the effect.
What is 140 mg/dL in mmol/L?
140 mg/dL is about 3.6 mmol/L. To convert, divide the mg/dL value by roughly 38.7.
Read more
- LDL cholesterol in the Medical Encyclopedia and cholesterol
- Lp(a) test: who should have it measured once
- Statins and atherosclerosis
General information only; it does not replace medical advice or an individual diagnosis. Last updated: November 2026.
Sources
- Mach F et al.: 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2020;41:111–188. pubmed.ncbi.nlm.nih.gov
- European Society of Cardiology: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. escardio.org
- European Atherosclerosis Society: What is new in the updated ESC/EAS Dyslipidaemia Guidelines? eas-society.org